A
Asian Institute of Urology and Nephrology
Specialty hospital network for urology and nephrology care
About Asian Institute of Urology and Nephrology
Asian Institute of Urology and Nephrology (AINU) is a super-specialty hospital network in India focused on renal sciences. It was founded in 2013 by a team of leading urologists and nephrologists, including Dr. C. Mallikarjuna and Dr. P. C. Reddy. Dr. Mallikarjuna serves as the Managing Director and Chief Consultant Urologist, bringing over 30 years of clinical expertise. Dr. Reddy, the Executive Director and a Chief Consultant Urologist, has over 29 years of experience.
The institution operates as a chain of single-specialty hospitals, providing comprehensive medical and surgical services in urology and nephrology. Its business model focuses on patient care through a network of hospitals located in cities like Hyderabad, Visakhapatnam, Siliguri, and Chennai. Revenue is generated from a wide range of services including consultations, diagnostic procedures, surgeries, and long-term care like dialysis. In September 2023, Asia Healthcare Holdings (AHH), a platform backed by TPG and GIC, acquired a majority stake in AINU for ₹600 crore to support its expansion.
AINU provides advanced treatments for conditions such as kidney stones, urological cancers, prostate diseases, and renal failure. The hospital network is equipped with modern facilities, including over 500 beds, multiple operating rooms, and 96 dialysis units. It has a strong focus on minimally invasive procedures, having completed over 1,200 robotic surgeries and more than 50,000 procedures in total. The nephrology department has conducted over 200,000 dialysis sessions and more than 300 kidney transplants. The hospital achieved NABH accreditation within two years of its inception, one of the youngest hospitals to do so.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Sep 2023 | $72M | $103M | Asia Healthcare Holdings | ↗ |
| OtherOther financing | Jan 2019 | $0 | — | HealthQuad | — |
Growth signals
Latest recorded traffic for Asian Institute of Urology and Nephrology is 11K monthly website visits, up 0% over the last three months. Asian Institute of Urology and Nephrology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Asian Institute of Urology and Nephrology in the Hyderabad ecosystem
The Asian Institute of Urology and Nephrology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
HealthQuad
Asia Healthcare Holdings
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Asian Institute of Urology and Nephrology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Asian Institute of Urology and Nephrology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






